Loading...

Regeneron Pharmaceuticals, Inc.

REGNNASDAQ
HealthcareBiotechnology
$489.52
$-115.87(-19.14%)
empty-state-iconNews data is not available for REGNNews details for REGN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

About Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals, Inc. (REGN) operates in the Healthcare sector and Biotechnology industry. It is commonly tracked by investors interested in this area of the market and contributes to overall trends within its sector.

While there may be no recent news or press releases available for REGN right now, you can still explore its price chart, viewAI-generated forecasts, or check the Meyka AI grade for a detailed assessment of fundamentals and market positioning.

This page will update automatically when new news, earnings events, or market developments related to Regeneron Pharmaceuticals, Inc. become available. Stay informed by checking back regularly.

Frequently Asked Questions